The Allstate Corporation (LON:0HCZ)

Revance Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	39,740	40,778	28,758	29,847	24,908	24,483
Market Cap Growth	16.71%	41.80%	-3.65%	19.83%	1.74%	-10.99%
Enterprise Value	46,598	48,157	35,779	37,350	31,732	30,514
PE Ratio	9.54	11.22	-	-	22.49	6.12
PS Ratio	0.82	0.80	0.64	0.70	0.67	0.80
PB Ratio	2.27	2.39	2.08	2.07	1.34	1.11
P/FCF Ratio	6.38	5.85	9.25	7.65	7.07	6.45
P/OCF Ratio	6.23	5.72	8.66	7.02	6.59	6.09
EV/Sales Ratio	0.93	0.94	0.80	0.88	0.85	0.99
EV/EBITDA Ratio	8.21	8.90	50.41	-	5.32	4.63
EV/EBIT Ratio	8.98	9.69	227.87	-	6.14	5.01
EV/FCF Ratio	7.48	6.91	11.51	9.57	9.01	8.04
Debt / Equity Ratio	0.34	0.39	0.47	0.46	0.34	0.28
Debt / EBITDA Ratio	1.08	1.21	8.16	-	1.02	0.91
Debt / FCF Ratio	0.95	0.95	2.07	1.69	1.77	1.61
Quick Ratio	0.29	0.22	0.24	0.23	0.24	0.17
Current Ratio	0.44	0.39	0.38	0.39	0.44	0.81
Asset Turnover	0.59	0.60	0.57	0.52	0.45	0.34
Return on Equity (ROE)	27.00%	23.59%	-1.22%	-6.32%	18.70%	19.31%
Return on Assets (ROA)	3.83%	3.62%	0.12%	-0.91%	3.88%	4.23%
Return on Capital (ROIC)	14.62%	14.01%	0.49%	-3.06%	12.12%	14.49%
Earnings Yield	10.48%	9.14%	-0.51%	-3.58%	4.78%	16.68%
Earnings Yield	10.48%	9.14%	-0.51%	-3.58%	4.78%	16.68%
FCF Yield	15.68%	17.08%	10.81%	13.07%	14.15%	15.51%
Dividend Yield	1.52%	1.93%	2.62%	2.65%	2.99%	2.24%
Payout Ratio	19.10%	23.12%	-	-	61.90%	13.92%
Buyback Yield / Dilution	-1.61%	-2.02%	3.21%	9.33%	5.20%	5.40%
Total Shareholder Return	-0.09%	-0.09%	5.83%	11.98%	8.19%	7.64%

Source: S&P Global Market Intelligence. Insurance template. Financial Sources.